NEW YORK (GenomeWeb News) – Metabolomics and biochemical analysis developer Metabolon has received Clinical Laboratory Improvement Amendment (CLIA) certification for its new facility in Research Triangle Park, NC.
The company said today that the CLIA certification from the Centers for Medicare and Medicaid Services will enable it to perform high-complexity tests on patient samples.
Metabolon said that later this year it plans to launch tests for insulin resistance and urological cancers based on biochemical markers.
The firm said its profiling technology identifies and measures all of the biochemicals in a biological sample in order to provide information about disease etiology, drug action, and other personalized medicine-related data.